These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24629043)

  • 1. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.
    Jansa P; Jarkovsky J; Al-Hiti H; Popelova J; Ambroz D; Zatocil T; Votavova R; Polacek P; Maresova J; Aschermann M; Brabec P; Dusek L; Linhart A
    BMC Pulm Med; 2014 Mar; 14():45. PubMed ID: 24629043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension in France: results from a national registry.
    Humbert M; Sitbon O; Chaouat A; Bertocchi M; Habib G; Gressin V; Yaici A; Weitzenblum E; Cordier JF; Chabot F; Dromer C; Pison C; Reynaud-Gaubert M; Haloun A; Laurent M; Hachulla E; Simonneau G
    Am J Respir Crit Care Med; 2006 May; 173(9):1023-30. PubMed ID: 16456139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.
    Chung WJ; Park YB; Jeon CH; Jung JW; Ko KP; Choi SJ; Seo HS; Lee JS; Jung HO;
    J Korean Med Sci; 2015 Oct; 30(10):1429-38. PubMed ID: 26425039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
    Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
    Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database.
    Song S; Lee SE; Oh SK; Jeon SA; Sung JM; Park JH; Chang HJ
    PLoS One; 2018; 13(12):e0209148. PubMed ID: 30566510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.
    Ling Y; Johnson MK; Kiely DG; Condliffe R; Elliot CA; Gibbs JS; Howard LS; Pepke-Zaba J; Sheares KK; Corris PA; Fisher AJ; Lordan JL; Gaine S; Coghlan JG; Wort SJ; Gatzoulis MA; Peacock AJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):790-6. PubMed ID: 22798320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.
    Roofthooft MT; Douwes JM; Vrijlandt EJ; Berger RM
    Am J Cardiol; 2013 Nov; 112(9):1505-9. PubMed ID: 23972345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
    Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
    Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
    Frost AE; Badesch DB; Barst RJ; Benza RL; Elliott CG; Farber HW; Krichman A; Liou TG; Raskob GE; Wason P; Feldkircher K; Turner M; McGoon MD
    Chest; 2011 Jan; 139(1):128-37. PubMed ID: 20558556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
    Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD
    Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
    Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
    JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry.
    Kang KY; Jeon CH; Choi SJ; Yoon BY; Choi CB; Lee CH; Suh CH; Lee CW; Cho CS; Nam EJ; Koh EM; Kim HY; Choi HJ; Kim HA; Jun JB; Lee J; Kim J; Ji JD; Min JK; Kim KJ; Shin K; So MW; Kwon SR; Kim SK; Nah SS; Kwok SK; Lee SK; Lee SW; Park SH; Park W; Park YB; Lee YH; Lee SS; Yoo DH
    Int J Rheum Dis; 2017 Sep; 20(9):1227-1236. PubMed ID: 26214170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
    Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.